Pricing: Free for Members, $99/Session for Non-Members

Wednesday, May 13, 2026

Program Description:

To participate in eLearning Day, you must register for each session individually by clicking the "Register" tab above and selecting the sessions you would like to attend.

11 am-12 pm ET

Unpacking the Data: The Application and Interpretation of Real-World Evidence in GLP-1 Obesity Treatment

GLP-1 agonists to treat obesity continue to challenge health plan sponsors as a major contributor to prescription drug spending, leading to widespread variation in coverage among health plans and employer groups. GLP-1 treatments for obesity hold the potential for improved health outcomes which could offset increasing prescription drug spending through reductions in medical costs. However, real-world evidence on this connection remains limited, with seemingly contradictory findings across analyses. Variation in study design and assessment contributes to these differences, creating challenges for managed care professionals seeking to leverage this evidence when making coverage decisions. This presentation will address the existing knowledge gap by reviewing the real-world evidence on GLP-1 products for obesity, exploring how variation in the design of these studies affects results, and describing how managed care decision-makers can leverage current evidence to inform GLP-1 coverage decisions. 

2-3 pm ET

Research Podium Session - Leveraging Real-World Data to Advance Managed Care Pharmacy Practice

Each year, hundreds of authors submit research abstracts to AMCP’s Annual Meeting. Accepted abstracts are presented as posters in the Expo Hall and published in a special issue of the Journal of Managed Care + Specialty Pharmacy. Top abstracts are awarded platinum ribbons and presented at the Research Podium Session.  

AMCP’s 2026 platinum abstracts had a common theme – use of real-world data to advance managed care pharmacy practice. In this Research Podium Session, authors will describe novel ways to leverage and link datasets to provide a deeper understanding of patients and outcomes.  

The platinum abstract presentations from AMCP 2026 that will be discussed during this webinar are: 

• GLP-1RA vs. SGLT2i: Preventing Kidney Function Deterioration Among Patients with Type 2 Diabetes and Chronic Kidney Disease 
• Characteristics Associated with Nonadherence from Data Collected as Part of an Automated Refill Reminder Program 
• Out-of-Pocket (OOP) Costs Burden for Prescription Drugs: Trends and Disparities in Commercial Insurance Design 

4-5 pm ET

Health Plan Best Practices in Psoriasis: Overcoming Access Barriers to Advanced Treatments

Sponsored and presented by Impact Education, LLC, separate registration required. Click here to register.

This activity is supported by an educational grant from Johnson & Johnson.

The psoriasis treatment landscape is rapidly evolving. Although treatment guidelines are routinely updated, ongoing innovation and the introduction of new therapies frequently render even the most current guidelines incomplete. During this symposium, expert faculty members will discuss solutions that managed care professionals can implement in their own settings to help aid in improving outcomes for patients with psoriasis. Faculty members will demonstrate the unique perspectives they bring to overall care recommendations for patients with psoriasis within a managed care setting.

Learning Objectives:

• Analyze the role of newly approved and emerging psoriasis therapies in care planning across different disease severities.
• Identify how comorbidities, patient history, and preferences influence treatment decisions.
• Access approaches to enhance timely, equitable access to evidence-based care for individuals living with psoriasis.

To Join Live Sessions:

• Join live sessions from your Pending Activities list by clicking the individual session name and then "Take Course." OR
• Click the "join session" link in the registration confirmation email; a separate email will be sent for each session you register for.